Congyu Ma, Ning Sheng, Jun Wu, Lulu Wang, Jiandong Jiang, Haibo Yu, Jinlan Zhang. Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438][J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 101025. doi: 10.1016/j.jpha.2024.101025
Citation:
|
Congyu Ma, Ning Sheng, Jun Wu, Lulu Wang, Jiandong Jiang, Haibo Yu, Jinlan Zhang. Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438][J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 101025. doi: 10.1016/j.jpha.2024.101025
|
Congyu Ma, Ning Sheng, Jun Wu, Lulu Wang, Jiandong Jiang, Haibo Yu, Jinlan Zhang. Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438][J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 101025. doi: 10.1016/j.jpha.2024.101025
Citation:
|
Congyu Ma, Ning Sheng, Jun Wu, Lulu Wang, Jiandong Jiang, Haibo Yu, Jinlan Zhang. Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438][J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 101025. doi: 10.1016/j.jpha.2024.101025
|
Corrigendum to “Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway” [J. Pharm. Anal. 14 (2024) 435–438]
-
Congyu Maa
,
-
Ning Shenga
,
-
Jun Wua
,
-
Lulu Wangb
,
-
Jiandong Jianga,b
,
,
,
-
Haibo Yua
,
,
,
-
Jinlan Zhanga
,
,
-
a. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China;
-
b. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
- Available Online:
Jul. 11, 2024
- Publish Date:
Jul. 09, 2024